EYE AGM Presentation
Filed with ASX · · 13 pages · English
DISCLAIMER: This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliability of any statement, estimates, opinions or other information contained in the presentation. This presentation
In the deck
Story so far
Earlier from Nova Eye Medical
- US Government Stimulus Loan Forgiven
- Aquisition of Glaucoma Patents
- FY21 Appendix 4E and Annual Report
- Full Year Results FY21
- FY21 Investor presentation
Later from Nova Eye Medical
- Glaucoma Sales Update
- Half year results discussion
- Investor presentation Half Year Results 31 December 2021
- Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance
- 2RT Pivotal Study and Regulatory Pathway
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical